SCHEMBL5529666

SCHEMBL5529666

Cc1ccc(Cn2cnc3ccccc3c2=O)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.67
TP53 P04637 2/20 0.67
RECQL P46063 1/20 0.67
MAPK10 P53779 1/20 0.67
LMNA P02545 3/20 0.64
HTT P42858 2/20 0.64
CYP11B1 P15538 1/20 0.64
CYP11B2 P19099 1/20 0.64
NPC1 O15118 1/20 0.64
MAPT P10636 1/20 0.64
RAB9A P51151 1/20 0.64
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
STAT3 P40763 1/20 0.57
HDAC1 Q13547 1/20 0.56
HDAC6 Q9UBN7 1/20 0.54
MEN1 O00255 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29692294 0.88 SMN1; SMN2 (0.64) SMN1; SMN2TP53RECQLMAPK10LMNA
SCHEMBL16210930 0.88 SMN1; SMN2 (0.64) SMN1; SMN2TP53RECQLMAPK10LMNA
SCHEMBL5532025 0.87 RAB9A (0.65) SMN1; SMN2RECQLMAPK10HTTCYP11B1
SCHEMBL17677816 0.85 GRK2 (0.64) SMN1; SMN2TP53RECQLMAPK10LMNA
SCHEMBL28738323 0.83 HDAC6 (0.61) SMN1; SMN2TP53RECQLMAPK10LMNA
SCHEMBL29065789 0.83 GRK2 (0.65) SMN1; SMN2TP53RECQLMAPK10
SCHEMBL24754468 0.82 SMN1; SMN2 (0.70) SMN1; SMN2TP53RECQLMAPK10HTT
SCHEMBL16220989 0.82 GRK2 (0.75) SMN1; SMN2TP53RECQLMAPK10HTT
SCHEMBL14048851 0.82 SCD (0.60) SMN1; SMN2TP53RECQLMAPK10HTT
SCHEMBL30669835 0.81 MCL1 (0.54) SMN1; SMN2TP53RECQLMAPK10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170305824-A1 SMALL MOLECULE INHIBITORS OF NECROPTOSIS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2017-10-26 US disclosed
US-20120122889-A1 SMALL MOLECULE INHIBITORS OF NECROPTOSIS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122889-A1 SMALL MOLECULE INHIBITORS OF NECROPTOSIS TNF, TNFRSF1A, RIPK1 SMN1; SMN2 2282/4885TP53 201/4885RECQL 3013/4885
US-20170305824-A1 SMALL MOLECULE INHIBITORS OF NECROPTOSIS TNF, TNFRSF1A, RIPK1 SMN1; SMN2 2346/4885TP53 203/4885RECQL 3040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.